Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP509422.RADcDnODYDhAwVQLeM2Xt23le8nyiMCW0FDRDZuZUiXyw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP509422.RADcDnODYDhAwVQLeM2Xt23le8nyiMCW0FDRDZuZUiXyw130_assertion type Assertion NP509422.RADcDnODYDhAwVQLeM2Xt23le8nyiMCW0FDRDZuZUiXyw130_head.
- NP509422.RADcDnODYDhAwVQLeM2Xt23le8nyiMCW0FDRDZuZUiXyw130_assertion description "[Losses of TP53 and/or PRDM1 were present in 52% of ALK(-)ALCL, and in 29% of all ALCL cases with a clinical implication.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP509422.RADcDnODYDhAwVQLeM2Xt23le8nyiMCW0FDRDZuZUiXyw130_provenance.
- NP509422.RADcDnODYDhAwVQLeM2Xt23le8nyiMCW0FDRDZuZUiXyw130_assertion evidence source_evidence_literature NP509422.RADcDnODYDhAwVQLeM2Xt23le8nyiMCW0FDRDZuZUiXyw130_provenance.
- NP509422.RADcDnODYDhAwVQLeM2Xt23le8nyiMCW0FDRDZuZUiXyw130_assertion SIO_000772 24004669 NP509422.RADcDnODYDhAwVQLeM2Xt23le8nyiMCW0FDRDZuZUiXyw130_provenance.
- NP509422.RADcDnODYDhAwVQLeM2Xt23le8nyiMCW0FDRDZuZUiXyw130_assertion wasDerivedFrom befree-20140225 NP509422.RADcDnODYDhAwVQLeM2Xt23le8nyiMCW0FDRDZuZUiXyw130_provenance.
- NP509422.RADcDnODYDhAwVQLeM2Xt23le8nyiMCW0FDRDZuZUiXyw130_assertion wasGeneratedBy ECO_0000203 NP509422.RADcDnODYDhAwVQLeM2Xt23le8nyiMCW0FDRDZuZUiXyw130_provenance.